Amneal Pharmaceuticals Inc.

AI Score

0

Unlock

8.52
-0.04 (-0.47%)
At close: Jan 22, 2025, 3:59 PM
8.52
0.06%
After-hours Jan 22, 2025, 04:00 PM EST

Amneal Pharmaceuticals Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Amneal Specialty Pharma Segment Revenue 115.64M 105.23M 753.89M 96.99M 91.68M 102.55M 89.48M 97.00M 85.09M 101.01M 92.75M 360.44M 312.51M 85.47M 87.87M 94.26M 985.00K 97.05M
Amneal Specialty Pharma Segment Revenue Growth +9.89%-86.04%+677.26%+5.80%-10.60%+14.60%-7.75%+14.00%-15.76%+8.91%-74.27%+15.34%+265.65%-2.73%-6.78%+9469.14%-98.99%n/a
Generics Segment Revenue 427.35M 391.29M n/a 373.70M 343.81M 399.17M 350.27M 364.89M 317.75M 346.27M 347.13M 88.64M 95.93M 342.14M 341.92M 306.56M n/a 300.28M
Generics Segment Revenue Growth +9.21%n/an/a+8.70%-13.87%+13.96%-4.01%+14.84%-8.24%-0.25%+291.64%-7.61%-71.96%+0.07%+11.53%n/an/an/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Generics Segment Revenue 1.47B 41.09M 35.97M 37.39M 1.29B 1.44B
Generics Segment Revenue Growth +3481.36%+14.24%-3.81%-97.09%-10.68%n/a
Specialty Segment Revenue 390.46M 374.12M 378.32M 355.57M 317.53M 223.96M
Specialty Segment Revenue Growth +4.37%-1.11%+6.40%+11.98%+41.78%n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016
Selling, General, and Administrative Revenue 118.69M 116.46M 112.59M 109.00M 113.01M 105.57M 102.10M 102.16M 100.07M 98.81M 98.67M 97.22M 91.40M 86.16M 90.73M 84.69M 83.12M 80.94M 77.98M 74.08M 63.80M 67.28M 84.44M 71.24M 78.08M 53.00M 25.12M 26.97M 27.44M 26.94M 27.70M 31.13M
Selling, General, and Administrative Revenue Growth +1.91%+3.43%+3.30%-3.54%+7.04%+3.40%-0.06%+2.09%+1.28%+0.14%+1.48%+6.38%+6.08%-5.04%+7.13%+1.89%+2.69%+3.81%+5.25%+16.12%-5.18%-20.32%+18.53%-8.76%+47.30%+110.99%-6.84%-1.73%+1.86%-2.76%-11.00%n/a
Research and Development Revenue 61.10M 37.10M 39.30M 46.56M 42.26M 38.62M 40.33M 43.27M 51.65M 51.57M 53.56M 53.02M 50.55M 54.23M 51.76M 57.16M 46.65M 49.12M 37.65M 53.02M 40.71M 50.53M 58.02M 60.53M 47.40M 54.38M 48.78M 46.23M 48.02M 52.11M 39.42M 43.51M
Research and Development Revenue Growth +64.70%-5.60%-15.60%+10.18%+9.43%-4.25%-6.78%-16.22%+0.15%-3.72%+1.03%+4.87%-6.78%+4.76%-9.44%+22.52%-5.03%+30.47%-29.00%+30.25%-19.43%-12.92%-4.15%+27.71%-12.84%+11.47%+5.54%-3.73%-7.86%+32.20%-9.41%n/a